BIOMAT Database Logo BIOMAT Database Logo

The need for renal biopsy in oncology patients on check-point inhibitors check-point inhibitors: New triggers for extracapillary glomerulonephritis extracapillary glomerulonephritis. 2023

M Dolores Sanchez de la Nieta Garcia, and Almudena Juez Del Pozo, and José Antonio Cortés Toro, and Antolina Rodríguez Moreno, and Clara García Carro, and Elena Ruiz Ferreras, and Ana Isabel Sánchez Fructuoso
Hospital Clínico San Carlos, Ciudad Real, Spain. Electronic address: sanchezdelanieta@senefro.org.

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies
D015432 Glomerulonephritis, Membranoproliferative Chronic glomerulonephritis characterized histologically by proliferation of MESANGIAL CELLS, increase in the MESANGIAL EXTRACELLULAR MATRIX, and a thickening of the glomerular capillary walls. This may appear as a primary disorder or secondary to other diseases including infections and autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Various subtypes are classified by their abnormal ultrastructures and immune deposits. Hypocomplementemia is a characteristic feature of all types of MPGN. C3G Complement 3 Glomerulopathy,Complement 3 Glomerulopathies,Complement 3 Glomerulopathy,Glomerulonephritis, Mesangiocapillary,MPGN Membranoproliferative Glomerulonephritis,Membranoproliferative Glomerulonephritis,Mesangiocapillary Glomerulonephritis,DDD MPGNII,Dense Deposit Disease,Glomerulonephritis, Hypocomplementemic,MPGNII,Membranoproliferative Glomerulonephritis Type II,Membranoproliferative Glomerulonephritis, Type I,Membranoproliferative Glomerulonephritis, Type II,Membranoproliferative Glomerulonephritis, Type III,Mesangiocapillary Glomerulonephritis, Type I,Mesangiocapillary Glomerulonephritis, Type II,Subendothelial Membranoproliferative Glomerulonephritis,Type II MPGN,DDD MPGNIIs,Glomerulonephritides, MPGN Membranoproliferative,Glomerulonephritides, Membranoproliferative,Glomerulonephritis, MPGN Membranoproliferative,Glomerulopathies, Complement 3,Glomerulopathy, Complement 3,Hypocomplementemic Glomerulonephritides,Hypocomplementemic Glomerulonephritis,MPGN Membranoproliferative Glomerulonephritides,MPGN, Type II,MPGNII, DDD,MPGNIIs,Membranoproliferative Glomerulonephritides,Membranoproliferative Glomerulonephritides, MPGN,Membranoproliferative Glomerulonephritis, MPGN,Membranoproliferative Glomerulonephritis, Subendothelial,Mesangiocapillary Glomerulonephritides,Type II MPGNs

Related Publications

M Dolores Sanchez de la Nieta Garcia, and Almudena Juez Del Pozo, and José Antonio Cortés Toro, and Antolina Rodríguez Moreno, and Clara García Carro, and Elena Ruiz Ferreras, and Ana Isabel Sánchez Fructuoso
Check point inhibitors a new era in renal cell carcinoma treatment.
May 2018, Medical oncology (Northwood, London, England),
M Dolores Sanchez de la Nieta Garcia, and Almudena Juez Del Pozo, and José Antonio Cortés Toro, and Antolina Rodríguez Moreno, and Clara García Carro, and Elena Ruiz Ferreras, and Ana Isabel Sánchez Fructuoso
Renal damage secondary to check-point inhibitors.
January 2020, Nefrologia,
M Dolores Sanchez de la Nieta Garcia, and Almudena Juez Del Pozo, and José Antonio Cortés Toro, and Antolina Rodríguez Moreno, and Clara García Carro, and Elena Ruiz Ferreras, and Ana Isabel Sánchez Fructuoso
Antimyeloperoxidase antibodies in patients with extracapillary glomerulonephritis.
January 1990, Nephron,
M Dolores Sanchez de la Nieta Garcia, and Almudena Juez Del Pozo, and José Antonio Cortés Toro, and Antolina Rodríguez Moreno, and Clara García Carro, and Elena Ruiz Ferreras, and Ana Isabel Sánchez Fructuoso
Circulating autoantibodies in patients with extracapillary glomerulonephritis.
January 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M Dolores Sanchez de la Nieta Garcia, and Almudena Juez Del Pozo, and José Antonio Cortés Toro, and Antolina Rodríguez Moreno, and Clara García Carro, and Elena Ruiz Ferreras, and Ana Isabel Sánchez Fructuoso
Cryoglobulinaemic glomerulonephritis: artefacts associated with laboratory diagnosis and need for renal biopsy.
May 2017, Internal medicine journal,
M Dolores Sanchez de la Nieta Garcia, and Almudena Juez Del Pozo, and José Antonio Cortés Toro, and Antolina Rodríguez Moreno, and Clara García Carro, and Elena Ruiz Ferreras, and Ana Isabel Sánchez Fructuoso
Editorial: severe colitis induced by targeted therapies in dermato-oncology beyond check point-inhibitors.
April 2023, Alimentary pharmacology & therapeutics,
M Dolores Sanchez de la Nieta Garcia, and Almudena Juez Del Pozo, and José Antonio Cortés Toro, and Antolina Rodríguez Moreno, and Clara García Carro, and Elena Ruiz Ferreras, and Ana Isabel Sánchez Fructuoso
Check point inhibitors as therapies for infectious diseases.
October 2017, Current opinion in immunology,
M Dolores Sanchez de la Nieta Garcia, and Almudena Juez Del Pozo, and José Antonio Cortés Toro, and Antolina Rodríguez Moreno, and Clara García Carro, and Elena Ruiz Ferreras, and Ana Isabel Sánchez Fructuoso
Micropolyarteritis and extracapillary/necrotizing glomerulonephritis in the elderly.
January 1993, Contributions to nephrology,
M Dolores Sanchez de la Nieta Garcia, and Almudena Juez Del Pozo, and José Antonio Cortés Toro, and Antolina Rodríguez Moreno, and Clara García Carro, and Elena Ruiz Ferreras, and Ana Isabel Sánchez Fructuoso
New Approaches in Glioblastoma Multiforme: The Potential Role of Immune- check Point Inhibitors.
January 2017, Current cancer drug targets,
M Dolores Sanchez de la Nieta Garcia, and Almudena Juez Del Pozo, and José Antonio Cortés Toro, and Antolina Rodríguez Moreno, and Clara García Carro, and Elena Ruiz Ferreras, and Ana Isabel Sánchez Fructuoso
[Plasmapheresis in the treatment of extracapillary glomerulonephritis (author's transl)].
May 1980, Medicina clinica,
Copied contents to your clipboard!